In this weeks episode we have updates for you from the FDA on approval of Retevmo, for multiple types of cancer and approval of Qinlock for gastrointestinal stromal tumors. We also have new indications to talk about with Rubraca and Lynparza, and we’ll also be giving our regular update on coronavirus numbers to date. Don't forget to like, share, & subscribe! Enjoy!